SecBot SecBot
8-K ·Filed Jul 15, 2026

NUVL

Nuvalent, Inc.
BULLISH
Impact 5/10
Horizonimmediate Processed4mo ago SEC0001193125-26-304126
8-K material event: Items 2.01, 5.01
Actionable Insight ▲ Bullish

Remaining shareholders who did not tender should promptly submit their shares to receive the $124.00 per share merger consideration. The stock will be delisted and deregistered, eliminating any further public trading. No remaining catalyst for the common equity.

DirectionBullish
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered BULLISH VIEWSTOCK AT ENTRY AT T+5
Entry
$123.96
T+0 close · Jul 15, 2026 · via day close
Latest settled
0.00%
T+5 · $123.96
Vs SPY
+0.98%
α at T+5
Next horizon
T+20
due 3mo ago
  1. T+0 · Jul 15 $123.96entry
  2. T+1 · 4mo ago 0.00%α +0.54% · $123.96
  3. T+5 · 4mo ago 0.00%α +0.98% · $123.96
  4. T+20 · due 3mo ago Pending
  5. T+60 · due 6w ago Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

GSK plc has completed its acquisition of Nuvalent, Inc. via a tender offer and merger. The tender offer expired with 91.3% of shares tendered, and the merger closed on July 15, 2026, at $124.00 per share in cash, representing a total equity value of approximately $10.6 billion. All outstanding shares, options, and RSUs were cashed out, and the company will be delisted from Nasdaq.

Key Facts

  • Tender offer expired on July 14, 2026 with 72,518,967 shares (91.3% of outstanding) validly tendered
  • Merger closed on July 15, 2026 under DGCL Section 251(h) without a stockholder vote
  • Shareholders received $124.00 per share in cash, less applicable withholding
  • Total equity value of the transaction approximately $10.6 billion
  • All outstanding stock options and RSUs were cancelled and converted to cash at the Offer Price
  • Nasdaq trading halted after market close on July 14, 2026; delisting and deregistration initiated
  • All incumbent directors and officers resigned; replaced by appointees of GSK's acquisition subsidiary
  • Certificate of incorporation and bylaws were amended and restated

Financial Impact

Transaction valued at approximately $10.6 billion in total equity value, with all outstanding shares converted to $124.00 cash per share. No ongoing public equity or financial reporting.

Risk Factors

  • Shareholders who do not tender or demand appraisal rights may face delays in receiving cash
  • Delisting and deregistration eliminate liquidity and public market access
  • Potential appraisal litigation if shareholders believe the price was inadequate

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
35% bullish (23 analysts)

Investment Themes

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-304126
Document: d52896d8k.htm0001193125-26-304126
Document: d52896dex31.htm0001193125-26-304126
Document: 0001193125-26-304126-index-headers.html0001193125-26-304126
Document: 0001193125-26-304126-index.html0001193125-26-304126
Document: 0001193125-26-304126.txt0001193125-26-304126

Track record

18 reports on NUVL

Performance horizon

4 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +21.01% at T+60 after the Apr 7, 2026 report. 4 of 7 went positive at some point.

Filters
  1. Jul 27, 202616w ago 15-12G Neutral 3/10 No price data
  2. Jul 15, 202617w ago 25-NSE Neutral 3/10 Entry $123.96 No price data
  3. Jul 15, 202617w ago 8-K Bullish 5/10 Viewing Entry $123.96 No price data
  4. Jul 8, 202618w ago Insider Cluster Neutral 3/10 Entry $123.80 No price data
  5. Jul 6, 202619w ago Insider Cluster Neutral 3/10 Entry $123.72 No price data
  6. Jun 11, 202622w ago Insider Cluster Neutral 2/10 Entry $123.25 to $123.90 ▲ +0.53% −1.25% vs SPY
  7. Jun 10, 202622w ago Insider Cluster Neutral 3/10 Entry $123.45 to $123.83 ▲ +0.31% −1.58% vs SPY
  8. Jun 9, 202622w ago 8-K Bullish 8/10 Entry $123.25 to $123.77 ▲ +0.42% −1.02% vs SPY
  9. May 7, 202627w ago 8-K Neutral 4/10 Entry $102.40 to $90.18 ▼ −11.93% −15.07% vs SPY
  10. Apr 29, 202628w ago Insider Cluster Neutral 2/10 Entry $99.10 to $107.38 ▲ +8.36% +2.90% vs SPY
Showing 10 of 18

US Market Status

Market Closed · Opens Wed (10h 22m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 15, 2026